Netherlands Antilles - Press Releases

  • 6708 Press Releases ยท
  • RSS
Published on Fri 21 Mar 2025 7:21:48 UTC
SAN DIEGO, March 20, 2025 /PRNewswire/ -- Senior Helpers, the nation's premier provider of in-home senior care services, is the first private duty in-home care provider inthe United Statesto be Age-Friendly Care at Home certified by Community Health Accreditation Partners (CHAP). On March 10, 2025,locally ownedSenior Helpers East San Diego joined the list of Senior Helpers CHAP Age-Friendly Care at Home Certified locations.
Published on Fri 21 Mar 2025 7:21:43 UTC
Built for movement and designed for every lifestyle, BRXL Activewear inspires confidence in the gym and beyond
Published on Fri 21 Mar 2025 7:21:39 UTC
FORT WORTH, Texas, March 20, 2025 /PRNewswire/ --In recognition of National Single Parent Day on March 21st, The Law Offices of Mark M. Childress is committed to supporting single parents by providing valuable guidance on helping children navigate the emotional challenges of divorce.
Published on Fri 21 Mar 2025 7:21:34 UTC
Come and See, Outreach Inc. and Gloo collaborate to connect churches to The Chosen preview footage and ministry resources
Published on Fri 21 Mar 2025 7:21:16 UTC
ALEXANDRIA, Va., March 20, 2025 /PRNewswire/ -- Today, President Donald Trump signed an executive order with the intention of dismantling the core functions of the U.S. Department of Education. National PTA President Yvonne Johnson issued the following statement on the executive action:
Published on Fri 21 Mar 2025 7:21:10 UTC
HOUSTON, March 20, 2025 /PRNewswire/ -- PCCA, a leading FDA-registered supplier of active pharmaceutical ingredients, excipients and consulting for the compounding industry, today announced Gus Bassani, PharmD,will become chief executive officer of its U.S. business unit on April 1, elevating a company veteran with extensive scientific leadership.
Published on Fri 21 Mar 2025 7:21:06 UTC
Journal of Emergency Nursing also honors emergency nursing legend
Published on Fri 21 Mar 2025 7:21:02 UTC
SAN CLEMENTE, Calif., March 20, 2025 /PRNewswire/ --Angelalign Technology Inc. ("Angelalign Technology" or the "Company") (6699.HK) released its financial results for fiscal year 2024. Driven by rapid expansion in global markets and continued innovation in digital orthodontics, the Company delivered a robust global performance despite complex global market challenges.
Published on Fri 21 Mar 2025 7:21:01 UTC
WASHINGTON, March 20, 2025 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2025 on Tuesday, April 22, 2025 beginning at 8:00 a.m. ET and lasting approximately one hour. During the call, the company will discuss its financial performance, as well as future expectations.
Published on Fri 21 Mar 2025 7:20:57 UTC
Comprehensive Analysis Exposes Severe Lung Diseases from Artificial Stone Dust Exposure
Published on Fri 21 Mar 2025 7:20:54 UTC
HIGHLAND PARK, Ill., March 20, 2025 /PRNewswire/ -- The Collaborative Community Housing Initiativeis excited to announce its recent acquisition of a former memory care community in Highland Park, Illinois. This purchase marks a significant step forward in CCHI's mission to create an inclusive living environment for individuals with intellectual and developmental disabilities.
Published on Fri 21 Mar 2025 7:20:51 UTC
Un anlisis exhaustivo expone enfermedades pulmonares graves por la exposicin al polvo de piedra artificial
Published on Fri 21 Mar 2025 7:20:47 UTC
Grant provides Native Veterans access to the Mobilized Native Intensive Clinical Program
Published on Fri 21 Mar 2025 7:20:41 UTC
DARZALEX has significant market potential as a leading monoclonal antibody for multiple myeloma treatment. Its approval in various combinations for both newly diagnosed and relapsed/refractory patients has expanded its reach. The multiple myeloma market is expected to grow steadily, with DARZALEX contributing significantly due to its strong clinical efficacy and growing adoption.
Published on Fri 21 Mar 2025 7:20:36 UTC
VICTORIA, BC, March 20, 2025 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere technology designed to optimize drug delivery for applications with significant unmet need, today announced its financial results for the fourth quarter of 2024. All dollar values are in U.S. dollars unless stated otherwise.
Published on Fri 21 Mar 2025 7:20:33 UTC
A case study on how a leading European dermatology company sought regulatory intelligence support to navigate the CDSCO framework. The company aimed to gain a comprehensive understanding of key guidelines, requirements, and approval processes to file their market-ready product in India successfully.
Published on Fri 21 Mar 2025 7:20:28 UTC
LOS ANGELES, March 20, 2025 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections, today announced financial results for its fourth quarter and full-year ended December 31, 2024, and provided a corporate update.
Published on Fri 21 Mar 2025 7:20:24 UTC
SAN FRANCISCO, March 20, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that the company will be webcasting its participation in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference:
Published on Fri 21 Mar 2025 7:20:22 UTC
TREMFYA is the only IL-23i to demonstrate clinical remission and endoscopic response, both at one year, with a fully subcutaneous induction regimen
Published on Fri 21 Mar 2025 7:20:17 UTC
HealthMark Group celebrates another year as a USA Today Top Workplace honoree, which recognizes companies nationwide taking the lead in employee satisfaction
Published on Fri 21 Mar 2025 7:20:14 UTC
EAST HANOVER, N.J., March 20, 2025 /PRNewswire/ -- Novartis today announced that oral Fabhalta (iptacopan) has received U.S. Food and Drug Administration (FDA) approval for the treatment ofadults with C3 glomerulopathy (C3G), to reduce proteinuria, making it the first and only treatment approved for this condition1-4.
Published on Fri 21 Mar 2025 7:20:13 UTC
ALPHARETTA, Ga., March 20, 2025 /PRNewswire/ -- OrthoMinds, LLC ("OrthoMinds") is providing notice of a recent data security event.OrthoMinds is notifying clients and potentially impacted individuals of the event. This notice provides information about the event, OrthoMinds' response, and steps potentially impacted individuals may take. OrthoMinds takes the confidentiality, privacy, and security of information very seriously.
Published on Fri 21 Mar 2025 7:20:09 UTC
The EUR2M grant will accelerate the development of an AI platform that addresses food industry sustainability challenges while unlocking new revenue opportunities and better, more affordable foods for consumers and pets.
Published on Fri 21 Mar 2025 7:20:08 UTC
ST. CHARLES, Mo., March 20, 2025 /PRNewswire/ -- Recon Supply, a leading provider of mission-critical equipment and logistical solutions, is proud to announce that it has been awarded an Equipment ECAT (Electronic Catalog) contract by the Defense Logistics Agency (DLA). This milestone solidifies Recon Supply's commitment to delivering high-quality, reliable equipment to support U.S. military and federal agency operations.
Published on Fri 21 Mar 2025 7:19:57 UTC
All-in-one platform will bring efficiency to financial planning and program execution across the national security ecosystem and beyond.